Seeing Is Believing
Currently out of the existing stock ratings of Reni Benjamin, 151 are a BUY (89.88%), 16 are a HOLD (9.52%), 1 are a SELL (0.6%).
Analyst Reni Benjamin, currently employed at JMP, carries an average stock price target met ratio of 44.18% that have a potential upside of 51.99% achieved within 180 days.
Reni Benjaminâs has documented 322 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KURA, Kura Oncology at 19-Nov-2024.
Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CTIC (CTI BIOPHARMA CORP) at 3/2/2022. The price target of $5 was fulfilled within 23 days with a profit of $1.63 (48.37%) receiving and performance score of 21.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$55
$34.71 (171.07%)
$55
1 months 5 days ago
(01-Nov-2024)
1/12 (8.33%)
$31.14 (130.51%)
83
Buy
$38
$17.71 (87.28%)
$38
1 months 5 days ago
(31-Oct-2024)
0/16 (0%)
$13.97 (58.14%)
Buy
$32
$11.71 (57.71%)
$32
2 months 20 days ago
(16-Sep-2024)
1/10 (10%)
$7.03 (28.15%)
174
Buy
$65
2 months 27 days ago
(09-Sep-2024)
0/5 (0%)
$49.66 (323.73%)
Buy
$28
$7.71 (38.00%)
$33
3 months 29 days ago
(07-Aug-2024)
1/7 (14.29%)
$3.62 (14.85%)
13
Which stock is Reni Benjamin is most bullish on?
Which stock is Reni Benjamin is most reserved on?
What Year was the first public recommendation made by Reni Benjamin?